Enliven Therapeutics, Inc. - Common Stock (ELVN)

Last Price26.72

Change-0.44 (-1.62%)

NASDAQ · Last Trade: Feb 14th, 7:51 AM EST

The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff

Issued on behalf of Oncolytics Biotech Inc.

By Equity Insider · Via GlobeNewswire · January 12, 2026

Active Biotech Alert: FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:ABBV),(NASDAQ:BGNE),(NASDAQ:HCM),(NASDAQ:ELVN) EQNX::TICKER_END

Via FinancialNewsMedia · October 4, 2024